Dashboard
Manage Tickers

EWTXEdgewise Therapeutics, Inc.

Nasdaq edgewisetx.com


$ 18.13 $ -0.05 (-0.28 %)    

Friday, 17-May-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -1.09 (-0.24 %)
DIA $ 399.76 $ 0.64 (0.16 %)
SPY $ 529.24 $ 0.31 (0.06 %)
TLT $ 91.40 $ -0.22 (-0.24 %)
GLD $ 223.63 $ 1.39 (0.63 %)
$ 18.18
$ 17.85
$ 18.11 x 200
$ 18.13 x 100
$ 17.47 - $ 18.13
$ 5.12 - $ 21.60
499,018
na
1.59B
$ 1.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

edgewise-therapeutics-files-for-mixed-shelf-offering-size-not-disclosed
Edgewise Therapeutics Files For Mixed Shel...
05/10/2024 13:10:32

- SEC Filing

edgewise-therapeutics-q1-eps-033-beats-039-estimate
Edgewise Therapeutics Q1 EPS $(0.33) Beats...
05/09/2024 13:05:41

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of...

top-5-health-care-stocks-that-could-sink-your-portfolio-in-q2
Top 5 Health Care Stocks That Could Sink Y...
05/09/2024 12:44:39

edgewise-therapeutics-doses-first-patient-in-phase-2-cirrus-hcm-trial-of-edg-7500-in-obstructive-hypertrophic-cardiomyopathy
Edgewise Therapeutics Doses First Patient ...
05/06/2024 12:12:36

Edgewise Therapeutics, Inc., (NASDAQ:EWTX), a leading muscle disease biopharmaceutical company, today announced the dosing of t...

edgewise-receives-ema-orphan-drug-designations-for-sevasemten-for-becker-and-duchenne-muscular-dystrophies
Edgewise Receives EMA Orphan Drug Designat...
04/23/2024 12:06:15

rbc-capital-maintains-outperform-on-edgewise-therapeutics-raises-price-target-to-32
RBC Capital Maintains Outperform on Edgewi...
04/22/2024 15:48:19

RBC Capital analyst Leonid Timashev maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and raises the price tar...

truist-securities-maintains-buy-on-edgewise-therapeutics-maintains-25-price-target
Truist Securities Maintains Buy on Edgewis...
04/17/2024 17:19:15

Truist Securities analyst Srikripa Devarakonda maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Buy and maintains $25 pr...

wedbush-reiterates-outperform-on-edgewise-therapeutics-maintains-26-price-target
Wedbush Reiterates Outperform on Edgewise ...
04/16/2024 14:19:17

Wedbush analyst Laura Chico reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $26 price target.

edgewise-therapeutics-reports-two-year-topline-results-from-arch-open-label-trial-of-sevasemten-in-adults-with-becker-muscular-dystrophy-sevasemten-was-well-tolerated
Edgewise Therapeutics Reports Two-Year Top...
04/15/2024 20:08:02

"We are pleased by the promising and consistent functional results observed over two years of treatment with sevasemten, to...

rbc-capital-reiterates-outperform-on-edgewise-therapeutics-maintains-28-price-target
RBC Capital Reiterates Outperform on Edgew...
03/12/2024 15:12:53

RBC Capital analyst Leonid Timashev reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $28 price...

piper-sandler-initiates-coverage-on-edgewise-therapeutics-with-overweight-rating-announces-price-target-of-48
Piper Sandler Initiates Coverage On Edgewi...
03/07/2024 10:22:14

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Edgewise Therapeutics (NASDAQ:EWTX) with a Overweight rating and ...

edgewise-therapeutics-to-present-on-edg-5506-for-the-treatment-of-becker-muscular-dystrophy-at-the-2024-mda-clinical-and-scientific-conference
Edgewise Therapeutics To Present On EDG-55...
02/28/2024 13:11:14

– Company to host an Industry Forum to discuss its approach to protecting and preserving dystrophic muscle featuring key opinio...

edgewise-therapeutics-q4-earnings-insights
Edgewise Therapeutics: Q4 Earnings Insights
02/22/2024 14:30:06

edgewise-therapeutics-q4-eps-047-misses-043-estimate
Edgewise Therapeutics Q4 EPS $(0.47) Misse...
02/22/2024 13:09:57

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate ...

how-is-the-market-feeling-about-edgewise-therapeutics
How Is The Market Feeling About Edgewise T...
01/31/2024 20:30:25

insiders-buying-edgewise-therapeutics-and-2-other-stocks
Insiders Buying Edgewise Therapeutics And ...
01/26/2024 11:34:40

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session
Why TransCode Therapeutics Shares Are Trad...
01/19/2024 18:05:18

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
01/19/2024 17:31:10

whats-going-on-with-edgewise-therapeutics-stock
What's Going On With Edgewise Therapeutics...
01/19/2024 16:33:54

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) shares are trading higher Friday after the company announced the pricing of its $240 ...

world-acceptance-posts-upbeat-earnings-joins-kaman-spirit-airlines-and-other-big-stocks-moving-higher-on-friday
World Acceptance Posts Upbeat Earnings, Jo...
01/19/2024 15:20:42

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporatio...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION